← Leaderboards
Andrew Orwick
University Of Louisville
$39,545
Attributed
$39,545
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $33.5K · FY2022–23$50K$37.5K$25K$12.5K$0
'22
'23
Funding mix
By agency
NIH$39,545 · 1
By mechanism
F31$39,545 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Louisville
Same institution · by research overlap
- Suresh C Tyagi$21,701,760
- Zhanxiang Zhou$11,702,941
- Donald M Miller$9,881,293
- Craig J McClain$36,863,296
- Douglas Chase Dean$9,729,332
Others in their field
Other Rising Stars on “Epithelial Cells”
- Julian A Symons · Hackensack University Medical Center$4,228,031
- Mariana Xavier Byndloss · Vanderbilt University Medical Center$3,864,845
- Julien Papillon · University Of Texas Med Br Galveston$3,556,177
- Fouad T Chebib · Mayo Clinic Jacksonville$2,967,657
- Caroline Uhler · Broad Institute, Inc.$2,967,486
- Christian Furlan Freguia · Rise Therapeutics, Llc$2,899,830
Research focus
Epithelial CellsFatty Acid OxidationAcute Renal Failure With Renal Papillary NecrosisEnergy-Generating ResourcesExcisionAftercareBioenergeticsBiogenesisBiopsyEffectivenessAutomobile DrivingCarcinomaCell DeathCellsCellular BiologyChronic Kidney FailureCisplatinClinicClinically RelevantDensityDoseCancer PatientCancer TypeFibrosis
Grant awards (2)
The role of PGC-1alpha in repeated low-dose cisplatin-induced kidney injury and the progression to chronic kidney disease$6,025
F31 · FY2023 · DK · contact PI
The role of PGC-1alpha in repeated low-dose cisplatin-induced kidney injury and the progression to chronic kidney disease$33,520
F31 · FY2022 · DK · contact PI